| Gene/Protein Targets | MAPK/ERK Kinase 1 (MEK1) constituitively active mutant |
| Relevance: | Disease model for psoriasis; in vivo study of constituitively active murine MEK1 mutant (S217E/S221E) in skin. |
| Model Type: | Conditional, Transgenic Models |
| Genetic Background: | CBA/C57BL/6 |
| Zygosity: | Heterozygous |
| Phenotype Keywords: | Skin abnormalities |
| Disease Keywords: | Psoriasis |
| Production Details: | An involucrin-MEK1 transgene expression construct was injected into male pronucleus of fertilised oocytes from F1 hybrid CBA/C57BL/6 mice. Transgene-positive mice were mated with wildtype F1 CBA/C57BL/6 to generate founder lines. |
| References: | Hobbs et al. 2004. Journal of Investigative Dermatology. 123:503-15. PMID: 15304090Read more |
| Notes: | The InvEE mouse presents a phenotype very similar to psoriasis, and is an ideal tool for study of the disease in vivo. InvEE mice demonstrate key features of human psoriasis: Abnormal keratinocyte differentiation; - hyperkeratosis - widespread thickening of the epidermis - Keratin10 expression delayed (no parakeratosis observed) - accumulation of cornified material on footpads, leading to development of horny masses - development of papillomas at sites of wounding Keratinocyte hyperproliferation; - scruffy coats, flaking epidermis - high numbers of Ki-67 and BrdU positive cells in all basal and suprabasal layers - Keratin14 staining in suprabasal layer - Keratin 6 and 7 expression in all epidermal layers Inflammatory skin lesions; - high numbers of CD4 (and some CD8) lymphocytes within epidermis - increased infiltration of macrophage and dendritic cells in the dermis, neutrophil infiltration in the dermis For more psoriasis disease models, see also Inv-a2b1 mouse; Inv-a3b1 mouse; Inv-a5b1 mouse. |
© Cancer Research Technology 2012